List of Excipients in API esomeprazole strontium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing esomeprazole strontium
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Amneal Pharmaceuticals of New York LLC | ESOMEPRAZOLE STRONTIUM | esomeprazole strontium | 53746-955 | CALCIUM CARBONATE | |
Amneal Pharmaceuticals of New York LLC | ESOMEPRAZOLE STRONTIUM | esomeprazole strontium | 53746-955 | FERRIC OXIDE RED | |
Amneal Pharmaceuticals of New York LLC | ESOMEPRAZOLE STRONTIUM | esomeprazole strontium | 53746-955 | GELATIN | |
Amneal Pharmaceuticals of New York LLC | ESOMEPRAZOLE STRONTIUM | esomeprazole strontium | 53746-955 | GLYCERYL MONOSTEARATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for esomeprazole strontium
Excipient focus: CALCIUM CARBONATE
esomeprazole strontium drug variants containing CALCIUM CARBONATE
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing CALCIUM CARBONATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
esomeprazole strontium drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
esomeprazole strontium drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
esomeprazole strontium drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
esomeprazole strontium drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
esomeprazole strontium drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
esomeprazole strontium drug variants containing GLYCERYL MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing GLYCERYL MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
esomeprazole strontium drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
esomeprazole strontium drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID
esomeprazole strontium drug variants containing METHACRYLIC ACID
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing METHACRYLIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
esomeprazole strontium drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
esomeprazole strontium drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
esomeprazole strontium drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
esomeprazole strontium drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
esomeprazole strontium drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
esomeprazole strontium drug variants containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals of New York LLC | esomeprazole strontium | 53746-955 |
Amneal Pharmaceuticals LLC | esomeprazole strontium | 65162-955 |
Sterling-Knight Pharmaceuticals LLC | esomeprazole strontium | 69336-129 |
R2 Pharma LLC | esomeprazole strontium | 70849-400 |
>Company | >Ingredient | >NDC |
esomeprazole strontium drug variants not containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.